Drug Profile
Hib-DTaP-hepatitis-B vaccine - Sanofi
Alternative Names: DTaP-HB-PRP-T; DTaP-HepB-Hib - Sanofi; UnifiveLatest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Class Haemophilus vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 29 Apr 2009 Discontinued - Phase-III for Diphtheria in Philippines (IM)
- 29 Apr 2009 Discontinued - Phase-III for Haemophilus infections in Philippines (IM)
- 29 Apr 2009 Discontinued - Phase-III for Hepatitis B in Philippines (IM)